Peter Walger
-
- Nosocomial Infections in ICU 3
-
- Blood Pressure and Hypertension Studies 6
- Nephrology top 5%
- Hematology top 10%
- Hemophilia Treatment and Research 3
- Platelet Disorders and Treatments 3
-
- Antibiotic Use and Resistance 5
-
- Streptococcal Infections and Treatments 3
-
- Sepsis Diagnosis and Treatment 3
-
- Antibiotics Pharmacokinetics and Efficacy 3
Peter Walger
38 papers receiving 920 citations
Peers
Comparison fields: 5 of 101
- Critical Care and Intensive Care Medicine 83
- Cardiology and Cardiovascular Medicine 313
- Nephrology 93
- Hematology 143
- Applied Microbiology and Biotechnology 17
Countries citing papers authored by Peter Walger
This map shows the geographic impact of Peter Walger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Walger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Walger more than expected).
Fields of papers citing papers by Peter Walger
This network shows the impact of papers produced by Peter Walger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Walger. The network helps show where Peter Walger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Walger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 2 | |
| 2 | 2017 | 6 | |
| 3 | 2016 | 9 | |
| 4 | 2015 | 11 | |
| 5 | 2008 | 1 | |
| 6 | 2008 | 31 | |
| 7 | 2008 | 20 | |
| 8 | 2007 | 14 | |
| 9 | 2006 | 8 | |
| 10 | 2006 | 8 | |
| 11 | 2003 | 1 | |
| 12 | 2003 | 22 | |
| 13 | 2001 | 2 | |
| 14 | 2000 | 26 | |
| 15 | [Severe soft tissue infection with bulla formation, sepsis, multiple organ failure]. | 1997 | 1 |
| 16 | 1991 | 123 | |
| 17 | 1989 | 32 | |
| 18 | 1989 | 12 | |
| 19 | 1987 | 2 | |
| 20 | [Ambulatory 24-hour blood pressure monitoring before and after dilatation of renal artery stenoses]. | 1986 | 1 |
About Peter Walger
Peter Walger is a scholar working on Applied Microbiology and Biotechnology, Family Practice and Critical Care and Intensive Care Medicine, having authored 43 papers that have together received 967 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (6 papers), Antibiotic Use and Resistance (5 papers), Streptococcal Infections and Treatments (3 papers), Hemophilia Treatment and Research (3 papers), Platelet Disorders and Treatments (3 papers), Nosocomial Infections in ICU (3 papers), Sepsis Diagnosis and Treatment (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (83 citations), Cardiology and Cardiovascular Medicine (313 citations) and Nephrology (93 citations). Peter Walger has collaborated with scholars based in Germany and Switzerland. Frequent co-authors include Peter Baumgart, H. Vetter, K. H. Rahn, M. von Eiff, G Ulrich‐Merzenich, Heike Zeitler, Gabriele Fuchs, Hans Jürgen Heppner, Hans‐Hermann Brackmann and L. Heß. Their work appears in journals such as Journal of Hypertension, The Nephron journals/Nephron journals, Obesity Surgery, Critical Care Medicine and Artificial Organs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.